Atropine
Active ingredient · 2 therapeutic classes
- Drug class
- Belladonna Alkaloids, Tertiary Amines
- Availability
- Prescription only
- Routes
- Intramuscular, Intravenous, Ophthalmic, Endotracheal, Intramedullary
- Markets covered
- 3
- Products on record
- 33
Overview
Atropine is an active pharmaceutical ingredient in the Belladonna Alkaloids, Tertiary Amines group (A03BA). The information below is compiled per regulator from the product labels on record, with direct links to the original documents.
Regulatory status by market
| Market | Regulator | Products | Last revision |
|---|---|---|---|
| GB United Kingdom | MHRA | 19 | May 1, 2026 |
| CA Canada | Health Canada | 8 | July 9, 2025 |
| US United States | FDA | 6 | March 10, 2026 |
GBUnited Kingdom· MHRA
19 products
Uses
Atropine sulfate Solution for injection is used: • As a preoperative medication for the reduction of salivary and bronchial secretions. • During cardiopulmonary resuscitation to treat sinus bradycardia or asystole. • For management of bradycardia of acute myocardial infarction.
g. arrhythmias, bradycardia) during surgery. • For treatment of symptomatic sinus bradycardia induced by drugs or toxic substances such as pilocarpine, organophosphate pesticides, amanita muscaria mushrooms. • In combination with neostigmine during reversal of effect of non- depolarising muscle relaxants.
How to take
CACanada· Health Canada
8 products
Uses
AND CLINICAL USE .................................................................................................................. 4 CONTRAINDICATIONS ...................................................................................................................................
4 WARNINGS .................................................................................................................................................... 5 PRECAUTIONS ...............................................................................................................................................
5 ADVERSE REACTIONS .................................................................................................................................... 6 OVERDOSAGE ................................................................................................................................................
6 DOSAGE AND ADMINISTRATION .................................................................................................................. 7 DOSAGE FORM, COMPOSITION, AND PACKAGING ......................................................................................
USUnited States· FDA
6 products
Uses
, as an antisialagogue, an antivagal agent, an antidote for organophosphorus or muscarinic mushroom poisoning, and to treat bradyasystolic cardiac arrest.
How to take
Drug interactions
Known interactions involving Atropine. Select one for details. This list is informational and not a complete interaction checker.
Showing 240 of 357. Type above to find a specific drug.
Interaction data compiled from DDInter (academic, CC-BY). Severity classification only - this is not a complete interaction checker and not medical advice.
Sources & citations
- [1]MHRA (UK) · PL018836169 · revised October 18, 2024
- [2]Health Canada (DPD) · 02426269 · revised July 9, 2025
- [3]FDA DailyMed · 0060b971-19bd-28… · revised January 28, 2024 [PDF]
Information on this page is compiled from public regulatory records. Drugvu is not affiliated with any regulator or pharmaceutical manufacturer. This is not medical advice. Always consult a qualified healthcare professional.